Clinical Trial Update: Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

View source ↗

Summary

This clinical trial investigates combining pyrotinib with trastuzumab and pertuzumab as maintenance therapy for HER2-positive advanced breast cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)
• Tyvyt (pyrotinib) (pyrotinib)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: HER2-positive Breast Cancer | Status: NOT_YET_RECRUITING